Testing how added radiation may work by immune and tumor markers
Part of Cancer clinical trials.
This study looks at people with non-metastatic invasive breast cancer who are getting curative breast surgery followed by planned radiation (sometimes with other anti-cancer medicines). Researchers want to understand whether a patient’s age and certain immune/tumor blood features can predict how well radiation helps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have invasive breast cancer confirmed by biopsy
- Your cancer has not spread to distant organs (no distant metastases)
- Your planned treatment includes curative breast-conserving surgery, with breast radiation
- Your radiation plan may include treating the nearby lymph drainage areas, if your doctor recommends it
- You have signed a consent form for the study
- You have not had radiation therapy before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests a specific plan that combines chemotherapy (and sometimes targeted medicines) with radiation before surgery for one breast. It may help shrink breast cancer and improve treatment timing, based on how well tumors respond.
This trial studies whether a specific radiation approach after lumpectomy can be helpful for certain people with early breast cancer that did not spread to lymph nodes at diagnosis. It focuses on people who finish neoadjuvant (before-surgery) treatment and reach a full response on final pathology.
This trial is testing whether giving radiation to nearby lymph nodes after surgery can help prevent breast cancer from coming back. It is for women with a specific type of breast cancer that has spread to a few lymph nodes but can be removed with surgery.
This trial studies whether giving radiotherapy after a mastectomy helps prevent breast cancer coming back in women whose lymph nodes are not involved (or only very tiny spread). It may help reduce recurrence risk, especially for patients with higher-risk features despite node-negative early cancer.
This trial studies whether adjusting radiation dose using how the tumor behaves can improve outcomes for people with locally advanced breast cancer that has spread to certain nearby lymph nodes. It may help deliver the right radiation intensity while avoiding unnecessary exposure.
This trial studies how different cancer treatments given before or after standard therapy affect breast cancer cells in the blood and bone marrow. It may help doctors better understand how treatments work throughout the body, not just where the tumor is.
Hear when a new Tumor Cell, Circulating trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.